About Multus
Multus is a company based in London (United Kingdom) founded in 2019 by Kevin Pan, Cai Linton, and Reka Tron. Multus has raised $9.3 million across 5 funding rounds from investors including UK Research and Innovation, European Union and Asahi Kasei. The company has 8 employees as of March 31, 2023. Multus operates in a competitive market with competitors including BioLife Solutions, RoosterBio, Shanghai Doning Biotechnology, ArunA Bio and Biotangents, among others.
- Headquarter London, United Kingdom
- Employees 8 as on 31 Mar, 2023
- Founders Kevin Pan, Cai Linton, Reka Tron
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Multus Biotechnology Limited
- Date of Incorporation 18 Mar, 2020
- Jurisdiction LONDON, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9.3 M (USD)
in 5 rounds
-
Latest Funding Round
$7 M (USD), Series A
Jan 16, 2023
-
Investors
UK Research and Innovation
& 10 more
-
Employee Count
8
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Multus
Unlock access to complete
Unlock access to complete
Funding Insights of Multus
Multus has successfully raised a total of $9.3M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $7 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Multus
Multus has secured backing from 11 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include UK Research and Innovation, European Union and Asahi Kasei.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in tech-enabled food chain sustainability startups.
|
Locked | Locked | Locked | |
|
Venture capital and accelerator services are provided across multiple sectors.
|
Locked | Locked | Locked | |
|
Investments are directed toward plant-based food innovations and technologies.
|
Locked | Locked | Locked |
Investor details for Multus
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Multus
Investment portfolio details for Multus
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Multus
Detailed financials for Multus
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Multus Comparisons
Peer comparison for Multus
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Multus
Multus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioLife Solutions, RoosterBio, Shanghai Doning Biotechnology, ArunA Bio and Biotangents, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| Locked | Locked | Locked |
Developer of human mesenchymal stem cells and extracellular vesicles
|
|
| Locked | Locked | Locked |
Serum-free cell culture media is supplied to biopharmaceutical industries.
|
|
| Locked | Locked | Locked |
Neural exosome platform is developed for neurodegenerative disease therapeutics.
|
|
| Locked | Locked | Locked |
Veterinary diagnostics products are developed for bovine viral diarrhea testing.
|
|
| Locked | Locked | Locked |
DNA-based flow reactors are developed for biochemical production.
|
Detailed competitors of Multus
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Multus
Complete news archive for Multus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Multus
Multus was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Multus is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Cai Linton is the current CEO of Multus. They have also founded this company.
Multus is a funded company, having raised a total of $9.3M across 5 funding rounds to date.
As of Mar 31, 2023, the latest employee count at Multus is 8.
Provider of lab-grown meat alternatives. The company claims it is using cells from livestock animals and multiplying them in the laboratory to obtain whole cuts of meat.
Multus's top competitors include FabricNano, RoosterBio and BioLife Solutions.
Multus has 11 investors. Key investors include UK Research and Innovation, European Union, Asahi Kasei, Mandi Ventures, and SOSV.